Last year about one in nine overweight adults with a prescription for any reason had at least one prescription for a weight loss drug, too
GI Adverse Effects of Glucagon-Like Peptide-1 Receptor Agonists These agents are commonly used therapies for managing diabetes and obesity, but gastrointestinal adverse effects such as nausea, vomiting, diarrhea, and constipation frequently limit therapy
I had more energy during the day and I didnt suffer from insomnia as often at night
Its also important to be aware of the potential for weight regain which can occur if lifestyle changes are not sustained
"These drugs have the potential to bring about substantial weight loss, particularly in the first year," says Juan Franco, co-lead researcher from Heinrich Heine University Dsseldorf, Germany